Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
September 7, 2022
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma
Leisa R Watson, Thomas E Lew, Lucy C Fox, et al.
Leukemia & Lymphoma
|
October 9, 2010
Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy
Rebecca Howman, Arti Thakerer, Matthew Pitman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 21, 2021
Advances in Frontline Management of Peripheral T-cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Cancers
|
October 29, 2020
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 5, 2021
Impact of an allied health prehabilitation service for haematologic patients receiving high-dose chemotherapy in a large cancer centre
Jessica Crowe, Jill J Francis, Lara Edbrooke, et al.
Blood
|
September 28, 2011
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
Claire E Dearden, Amit Khot, Monica Else, et al.
Internal Medicine Journal
|
June 20, 2025
A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years
Rory Bennett, Thomas Frawley, Philip A Thompson, et al.
British Journal of Haematology
|
November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
Sueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Bone Marrow Transplantation
|
July 21, 2021
T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease
Thomas E Lew, Edward R S Cliff, Michael Dickinson, et al.
Expert Review of Hematology
|
December 22, 2021
The development of a home-based therapeutic platform for multiple myeloma
Hayley Beer, David Routledge, Trish Joyce, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
September 7, 2022
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma
Leisa R Watson, Thomas E Lew, Lucy C Fox, et al.
Leukemia & Lymphoma
|
October 9, 2010
Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy
Rebecca Howman, Arti Thakerer, Matthew Pitman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 21, 2021
Advances in Frontline Management of Peripheral T-cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Cancers
|
October 29, 2020
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 5, 2021
Impact of an allied health prehabilitation service for haematologic patients receiving high-dose chemotherapy in a large cancer centre
Jessica Crowe, Jill J Francis, Lara Edbrooke, et al.
Blood
|
September 28, 2011
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
Claire E Dearden, Amit Khot, Monica Else, et al.
Internal Medicine Journal
|
June 20, 2025
A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years
Rory Bennett, Thomas Frawley, Philip A Thompson, et al.
British Journal of Haematology
|
November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
Sueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Bone Marrow Transplantation
|
July 21, 2021
T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease
Thomas E Lew, Edward R S Cliff, Michael Dickinson, et al.
Expert Review of Hematology
|
December 22, 2021
The development of a home-based therapeutic platform for multiple myeloma
Hayley Beer, David Routledge, Trish Joyce, et al.
Page
of 7